Bangor University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Bangor United Kingdom (1884)

Organization Overview

First Clinical Trial
2007
NCT00514410
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bangor University | Bangor Unversity

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dementia (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Epilepsy (Phase 4)

Epilepsy, Rolandic (Phase 4)

Pancreatitis (Phase 2)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 14